Physician profile
David Yan
NPI 1265585939
$1,451.95
in general payments reported to CMS, 2019-2025
20 companies · $610 in 2025
The $610 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $28.98 · 2021: $16.85 · 2022: $438 · 2023: $189 · 2024: $58.36 · 2025: $610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $857.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $306.78 | 2022-2025 | Natrelle Saline-Filled Breast Implants |
| Mentor Worldwide LLC | $216.92 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Musculoskeletal Transplant Foundation INC. | $169.90 | 2022 | |
| Baxter Healthcare | $145.62 | 2025 | Tisseel |
| Sientra, INC. | $95.14 | 2022 | |
| Rti Surgical, INC | $86.19 | 2025 | |
| Allergan, INC. | $82.31 | 2022 | |
| Smith+Nephew, INC. | $70.18 | 2019-2024 | Collagenase Santyl |
| Stryker Corporation | $46.87 | 2023 | 1688 |
| Davol INC. | $44.35 | 2025 | Arista |
| Motiva USA, LLC | $36.59 | 2025 | |
| Therapeuticsmd, INC. | $22.01 | 2019 | |
| Polymedics Innovations INC. | $19.13 | 2024 | |
| Amgen INC. | $18.70 | 2019 | |
| Merck Sharp & Dohme LLC | $16.85 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $15.92 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $15.57 | 2023 | Evkeeza |
| Amag Pharmaceuticals, INC. | $14.56 | 2019 | |
| Novo Nordisk INC | $14.38 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $13.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Yan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.